Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$784M |
| 2 |
Amgen
AMGN
|
$695M |
| 3 |
Eli Lilly
LLY
|
$512M |
| 4 |
Apple
AAPL
|
$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$471M |
Top Sells
| 1 |
Adobe
ADBE
|
$935M |
| 2 |
NVIDIA
NVDA
|
$837M |
| 3 |
TJX Companies
TJX
|
$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$364M |
| 5 |
Starbucks
SBUX
|
$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Medtronic
MDT
$119B
| $191M | 0.1% |
2,430,651
-1,056,843
| -30% | -$83.2M |
|
177
Dentsply Sirona
XRAY
$2.92B
| $188M | 0.1% |
7,562,367
+29,903
| +0.4% | +$745K |
|
178
Micron Technology
MU
$147B
| $187M | 0.1% |
1,424,787
-701,294
| -33% | -$92.2M |
|
|
AVDL
179
Avadel Pharmaceuticals
AVDL
$1.53B
| $187M | 0.1% |
13,297,317
+382,157
| +3% | +$5.38M |
|
180
Chart Industries
GTLS
$8.96B
| $183M | 0.1% |
1,266,744
+166,791
| +15% | +$24.1M |
|
181
Ryan Specialty Holdings
RYAN
$6.96B
| $182M | 0.1% |
3,134,930
+39,126
| +1% | +$2.27M |
|
182
Qualcomm
QCOM
$172B
| $181M | 0.1% |
909,128
-570,681
| -39% | -$114M |
|
183
Walker & Dunlop
WD
$2.98B
| $180M | 0.1% |
1,836,027
-162,118
| -8% | -$15.9M |
|
184
Revolution Medicines
RVMD
$7.57B
| $180M | 0.1% |
4,640,218
+728,099
| +19% | +$28.3M |
|
185
Dollar Tree
DLTR
$20.6B
| $179M | 0.1% |
1,679,364
+315,938
| +23% | +$33.7M |
|
186
Wayfair
W
$11.6B
| $177M | 0.1% |
3,363,518
+1,735,806
| +107% | +$91.5M |
|
187
Coca-Cola
KO
$292B
| $175M | 0.09% |
2,750,209
+288,247
| +12% | +$18.3M |
|
|
CTLT
188
DELISTED
CATALENT, INC.
CTLT
| $174M | 0.09% |
3,094,620
-6,466,078
| -68% | -$364M |
|
189
Ziff Davis
ZD
$1.56B
| $174M | 0.09% |
3,152,339
-87,315
| -3% | -$4.81M |
|
190
Glaukos
GKOS
$5.39B
| $172M | 0.09% |
1,457,533
-153,355
| -10% | -$18.1M |
|
191
Sotera Health
SHC
$4.44B
| $172M | 0.09% |
14,492,836
-400,032
| -3% | -$4.75M |
|
192
Mirum Pharmaceuticals
MIRM
$3.82B
| $171M | 0.09% |
4,988,747
+2,221,537
| +80% | +$76M |
|
193
Prologis
PLD
$105B
| $166M | 0.09% |
1,474,801
-189,535
| -11% | -$21.3M |
|
194
Sensient Technologies
SXT
$4.79B
| $165M | 0.09% |
2,229,750
-181,683
| -8% | -$13.5M |
|
195
Motorola Solutions
MSI
$79.8B
| $165M | 0.09% |
426,836
+68,630
| +19% | +$26.5M |
|
196
Capital One
COF
$142B
| $165M | 0.09% |
1,190,082
-26,642
| -2% | -$3.69M |
|
197
Dyne Therapeutics
DYN
$2.02B
| $163M | 0.09% |
4,623,824
+1,948,584
| +73% | +$68.8M |
|
198
AXIS Capital
AXS
$7.62B
| $163M | 0.09% |
2,302,960
-18,311
| -0.8% | -$1.29M |
|
199
OSI Systems
OSIS
$3.93B
| $162M | 0.09% |
1,179,310
-70,579
| -6% | -$9.71M |
|
200
Marathon Petroleum
MPC
$54.8B
| $162M | 0.09% |
934,320
-298,159
| -24% | -$51.7M |
|